Formed from three specialist CDMOs, Bend Bioscience offers bigger solutions and bolder science across small molecule capabilities and enabling technologies. From pre-clinical to commercial scale, Bend combines the broad capabilities of a large CDMO with the flexibility and speed of an expert partner. Our partnering approach brings molecules through the clinic, to scaled manufacturing and launch via our network of three specialized facilities in the U.S.. We offer accelerated solutions for orphan, breakthrough and specialty programs, as well as tech transfer expertise to ease to ease transition from early development to commercial production.
